Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
: 10-20 /
Am J Med 2015;128:1281e7
La L-carnitina favorece la entrada de cidos grasos de cadena larga en la mitocondria
Diabetes Care 38 , 9196 (2015)
doi: 10.1161/CIRCULATIONAHA.125.074545 Summary Keywords cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes Citation Aristizbal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, Lpez-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gmez-Mesa J-E, Abreu-Lomba A and Rivera-Martnez W-A (2025) A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists a comprehensive review
US$ 26.78
US$ 21.50
US$ 26.80
US$ 27.80
US$ 26.37
US$ 26.01
US$ 27.30
US$ 25.92
US$ 20.00
US$ 20.85
